- Home
- ATLO vs LXEO Comparison
ATLO vs LXEO Comparison
Compare ATLO & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- LXEO
- Stock Information
- Founded
- ATLO 1903
- LXEO 2017
- Country
- ATLO United States
- LXEO United States
- Employees
- ATLO N/A
- LXEO N/A
- Industry
- ATLO Major Banks
- LXEO
- Sector
- ATLO Finance
- LXEO
- Exchange
- ATLO Nasdaq
- LXEO Nasdaq
- Market Cap
- ATLO 166.6M
- LXEO 140.6M
- IPO Year
- ATLO N/A
- LXEO 2023
- Fundamental
- Price
- ATLO $17.52
- LXEO $3.47
- Analyst Decision
- ATLO
- LXEO Strong Buy
- Analyst Count
- ATLO 0
- LXEO 5
- Target Price
- ATLO N/A
- LXEO $22.80
- AVG Volume (30 Days)
- ATLO 12.1K
- LXEO 894.5K
- Earning Date
- ATLO 05-07-2025
- LXEO 03-24-2025
- Dividend Yield
- ATLO 4.52%
- LXEO N/A
- EPS Growth
- ATLO N/A
- LXEO N/A
- EPS
- ATLO 1.14
- LXEO N/A
- Revenue
- ATLO $53,455,000.00
- LXEO N/A
- Revenue This Year
- ATLO N/A
- LXEO N/A
- Revenue Next Year
- ATLO N/A
- LXEO N/A
- P/E Ratio
- ATLO $15.58
- LXEO N/A
- Revenue Growth
- ATLO 2.24
- LXEO N/A
- 52 Week Low
- ATLO $15.69
- LXEO $2.32
- 52 Week High
- ATLO $22.03
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- ATLO 39.13
- LXEO 48.25
- Support Level
- ATLO $17.45
- LXEO $3.75
- Resistance Level
- ATLO $17.91
- LXEO $4.59
- Average True Range (ATR)
- ATLO 0.32
- LXEO 0.50
- MACD
- ATLO -0.05
- LXEO 0.18
- Stochastic Oscillator
- ATLO 23.30
- LXEO 47.17
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.